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INTRODUCTION 
 
Hypertensive disorders during pregnancy constitute the 
most common medical disorders encountered by 
obstetricians. The incidence is 7% to 10 %, of which pre 
eclampsia and eclampsia constitute 70% and chronic 
hypertension 30%. It remains the leading cause for maternal 
mortality and morbidity worldwide accounting for 15 % to 
20%. 
 
Pre eclampsia/eclampsia is a multi organ disorder 
unique to human pregnancy. The typical renal lesionsis 
glomeruloendotheliosis, which is the swelling of the 
glomerular capillary endothelial and mesangial cells. 
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Involvement of renal system is well before the 
symptomatology of pre elampsia manifest.  
Pritchard stated that the presence of chorionic villi in 
women with pre eclampsia causes vasospasm leading to 
development of hypertension and serious multiorgan 
dysfunction, specifically confined to placenta, kidneys, liver 
and sometimes brain.  
 
As per many studies, presence of placenta is sufficient 
for development of pre eclampsia, there is no necessity of 
fetus, as pre eclampsia is seen is complete mole, there is no 
necessity of uterus as it can be seen in abdominal pregnancy 
also. So the pathogenesis of pre eclampsia will start as early 
as the trophoblastic invasion, so any insult at that time can 
lead to development of hypertension during pregnancy.  
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So prediction of pre eclampsia earlier helps in early 
intervention and prevention of pre eclampsia. So many 
research workers are more towards the way of predicting pre 
eclampsia there by, primary prevention.  
 
According to World Health Organization, hypertensive 
diseases during pregnancy are a major cause of perinatal 
mortality and morbidity. Hypertension in pregnancy is 
defined as, systolic blood pressure >= to 140, diastlolic blood 
pressure >= to 90 mm of Hg associated with proteinuria.  
 
Hypertension in pregnancy is a challenge in modern 
obstetrics. Many people from different departments of 
medical practice have been involved in the research purposes. 
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Though the etiology of hypertensive disorder in pregnancy 
have been explained by many research workers over many 
years, the etiology  remains unclear even today. 
Many systems affected due to hypertension in pregnancy. In 
women with preeclampsia, renal function changes develop 
well before establishment of the symptoms and signs of pre 
eclampsia.  
 
Many research works have been done to establish the 
correlation between hypocalciuria and development of pre 
eclampsia, so that it can be used as early predictor of pre 
eclampsia.  
 
Several studies have been done in the past to find out 
the role of reduced excretion of calcium early detection of 
preeclampsia. In the early 1980 s they have shown that these 
6 
 
investigations may be used as a screening method in 
predicting hypertension in pregnanacy.  
Since then, various trails have been trying to detect 
effectiveness of hypocalciuria in predicting pre eclampsia. 
Many other trials have failed to show the effectiveness of the 
low calcium excretion as a screening method.  
 
So the need to establish the predictive values of this 
investigation and thus the efficacy as a screening test in 
predicting the high risk women. Multiple predictive tests 
have be put forth till date for prediction of pre eclampsia, but 
all of limited use for example, 
ROLL OVER TEST 
A hypertensive response induced by having women at 
28 to 32 weeks of gestation assume supine position after 
lying laterally recumbent predicts gestational  hypertension 
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ANGIOTENSIN SENSITIVITY TEST 
A woman destined to get pre eclampsia will respond to 
less than 8ng/kg/min of n angiotensin infusion due to an 
alteration in vessel wall refractoriness,this test done between 
26 to 30weeks.  
PLATELET VOLUME 
Thrombocytopenia and platelet dyfunction are the 
integral features of pre eclampsia. Increased destruction 
causes the platelet volume to increase because of relatively 
younger and therefore larger platelets entering the 
circulation. Ahmed et al found high platelets volumes to be a 
marker of impending pre eclampsia but with a substantive 
overlap with normotensive women. 
SERUM FIBRONECTIN 
Endothelial cell activation is the likely cause of 
elevated serumcellular fibronectin value in the population 
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with pre –eclampsia,in a study those levels rise within 12 
weeks of gestation are high risk  for developing  pre 
eclampsia 
UTERINE ARTERY DOPPLER  
Uterine artery impedance between 18 to 26 weeks is 
being used as an early predictor of pre eclampsia. 
ANTOTHROMBIN III LEVELS  
URINARY KALLIKREIN EXCRETION 
Ratio <170 between 16 to 20 weeks of pregnancy 
predicts pre eclampsia. 
 
Though many number of predictive tests are available, 
none has been proved to be very sensitive and specific to 
predict pre eclampsia. Hence many randomized control trials 
are to be conducted to prove one test which is both sensitive 
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and specific to predict pre eclampsia, with good positive and 
negative predictive value. 
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AIM 
To Asses the predictive value of calcium creatinine 
ratio in spot urine sample for early prediction of pre 
eclampsia 
 
OBJECTIVES 
To asses predictive value of calcium creatinine ratio 
To asses maternal outcome  
To assess the mode of delivery  
To assess the fetal outcome 
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REVIEW OF LITERATURE 
Hypertensive disorders of pregnancy constitute the 
most common medical disorders encountered by 
obstetricians.  
The incidence is 7% to 10 %,of which pre eclampsia/ 
eclampsia constitute 70% and chronic hypertension 30%. It 
remans the leading cause for maternal mortality and 
morbidity worldwide accounting for 15 % to 20%. 
 
Pre eclampsia/eclampsia is a multi organ disorder 
unique to human pregnancy. Pritchard stated that the 
presence of chorionic villi in certain women incites 
vasospasm, hypertension and serious organ dysfunction, 
especially of placenta, kidneys, liver and sometimes brain. 
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Multiple predictive tests have be put forth till date for 
prediction of pre eclampsia, but all of limited use for 
example, 
ROLL OVER TEST 
A hypertensive response induced by having women at 
28 to 32 weeks of gestation assume supine position after 
lying laterally recumbent predicts gestational hypertension 
ANGIOTENSIN SENSITIVITY TEST 
A woman destined to get pre eclampsia will respond to 
less than 8ng/kg/min of angiotensin infusion due to an 
alteration in vessel wall refractoriness, this test done between 
26 to 30weeks.  
PLATELET VOLUME 
Thrombocytopenia and platelet dyfunction are the 
integral features of pre eclampsia. Increased destruction 
causes the platelet volume to increase because of relatively 
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younger and therefore larger platelets entering the 
circulation. Ahmed et al found high platelets volumes to be a 
marker of impending pre eclampsia but with a substantive 
overlap with normotensive women. 
SERUM FIBRONECTIN 
Endothelial cell activation is the likely cause of 
elevated serum cellular Fibronectin levels in high risk 
women. Study those levels rose within 12 weeks of 
pregnancy are intended to progress to develop pre eclampsia. 
UTERINE ARTERY DOPPLER  
Uterine artery impedence between 18 to 26 weeks has 
been used as an early screening test for women at risk of pre 
eclampsia. 
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ANTOTHROMBIN III LEVELS  
URINARY KALLIKREIN EXCRETION  
Ratio <170 between 16 to 20 weeks of pregnancy predicts 
pre eclampsia. 
 
Though many number of predictive tests are available, 
none has been proved to be very sensitive and specific to 
predict pre eclampsia. Hence many randomized control trials 
are to be conducted to prove one test which is both sensitive 
and specific to predict pre eclampsia 
 
Prediction of pre eclampsia by using urinary CCR, a 
study conducted in queen Elizabeth hospital, woodvile, by 
Raniolo E et al, this was a prospective study, calcium 
creatinine ratio was estimated in 392 women, they concluded 
that calcium to creatinine ratio assessed in symptomatic 
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antenatal mothers at 20 to 30 weeks gestation was not a 
satisfactory predictive marker for development of pre 
eclampsia.  
The major variation among different population, in 
calcium levels suggests that it cannot be used as a screening 
method. 
 
Phuapradit W et al, conducted a study in the OBG 
Department, Mahidol University, Thialand, they assessed 190 
primigravidas, at 28 to 32 weeks of pregnancy without any 
risk factors, were involved in the study . 
Pre ecalmpsia was noted in 6.8% of samples, pateints 
with pre eclampsia did not demonstrate reduced excretion of 
calcium than normal population (2).  
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Study conducted by Kazerooni T et al in Shiraz 
University Shiraz, Iran. Study involved 200 women; they 
showed that CCR was appreciably less in pre eclampsia 
patients with a significant P value.  
 
They concluded that, Calcium creatinine ratio can be 
used as mode of routine screening for early prediction of pre-
eclampsia. (3) 
 
Anai T, et al, conducted study in the Department of 
Obstetrics and Gynecology, Medical College of Oita. 
Hypocalciuria in women with preeclampsia.  
 
To assess the significance of hypocalciuria in pregnant 
women, 24-hour urinary calcium excretion and the CCR 
(mg/g) in random urine samples were measured in the 
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following 4 groups: 3 mild preeclamptic patients, 5 severe 
preeclamptic patients, 4 patients with intrauterine growth 
retardation (IUGR), and 10 healthy pregnant women.  
 
The mean 24-hour urinary calcium excretion in the 4 
groups was 44.3 +/- 21.3 mg/day, 11.6 +/- 2.7 mg/day, 161.4 
+/- 80.4 mg/day and 145.0 +/- 45.0 mg/day, respectively. 
Calcium excretion was significantly lower in the mild and 
severe preeclamptic patients than in the women with IUGR 
and the normal pregnant women.  
 
There was also a significant difference between the 
value in the mild and severe preeclamptic patients. The mean 
calcium/creatinine ratio in random urine samples was 53 +/- 
30 mg/g, 18 +/- 5.6 mg/g, 192 +/- 85 mg/g and 169 +/- 70 
mg/g, respectively. Also, such significant as 24-hour urinary 
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calcium excretion were found in the mean calcium/creatinine 
ratio. 
They concluded saying that determination the CCR in 
random urine samples is a reliable index of preeclampsia.(4) 
 
Study conducted by Ozcan T et al in the Maternity 
Hospital, Turkey. 
They conducted a study by testing the CCR and the 
calcium level in urine sample in 56 antenatal mothers, 44 
among the 56 samples had normal CCR and hypertension 
developed in 8. The mean CCR was estimated the values to 
be significantly lower in the preeclamptic group compared 
with the normal group with significant p value. 
A threshold value of CCR was 0.066 for the CCR were 
statistically analysed and had sensitivity of 75%, a specificity 
of 86%, and a positive and negative predictive value of 55% 
21 
 
and 95%, respectively. The results conclude that CCR can be 
used as screening tool for prediction of pre eclmapsia. 
 
Saudan PJ et al conducted a study in Dept of Renal 
Medicine, University of New South Wales, Australia. 
They wanted to prove the fact that Hypocalciuria has 
been associated with hypertensive disorder in pregnancy with 
or without proteinuria, but not with normal pregnancy.  
They stressed up on the fact that reduced CCR has high 
sensitivity in detecting the pre eclampsia among high risk 
women. 81 antenatal mothers with established hypertension 
after 12 weeks of pregnancy were included in the study. 
The CCR was determined in a sp urine sample at first 
visit. The Patients were observed and subsequently classified 
according to development of preeclampsia post natally.on 
follow up, patients who developed pre eclampsia had low 
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calcium excretion antenatally, compared to the population 
who remained normotensive. Results of statistical analyses 
revealed sensitivity 68% and a specificity of 70%. 
The pathogenesis of renal involvement in pre eclampsia 
has been proved to occur well before the establishment of 
symptoms. 
 This test cannot be used as a sceerning test as the test 
lacks sensitivity, as a predictor of pre eclampsia  
 
Kazerooni T published a study conducted in Iran,  
The trail conducted to define the predictive value of 
CCR in prediction of pre eclampsia. The CCR ratio was 
determined in a urine sample of 102 normal antenatal 
mothers from 20-24 weeks of pregnancy. The women were 
observed and categorized according to occurrence of pre-
eclampsia. 
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The CCR was compared, were correlated by prevalence 
pre eclampsia. 8 women developed pre-eclampsia and 94 
were found to have normal blood pressure. The variables like 
age, time of enrollment to the study and time of delivery 
were compared between the two groups, and they did not 
show any association.  
Mean urinary calcium concentration in normotensive 
and pre eclampsia women, were statistically significant,  with 
hypoclaciuria in pre eclampsia women ,with significant P 
value.   
They concluded that in pre eclamptic group calcium 
creatinine ratio was low compared to normotensive group. 
spot urinary CCR can be efficacious mode of assessment of 
high risk women .(7) 
  
24 
 
Calcium excretion in preeclampsia was assessed by 
Sanchez-Ramos L et al in the Dept of OBG, Florida Health 
Science Center, Florida. 
They compared 24-hour urine data from 143 obstetric 
patients: 33 with preeclampsia, 58 normotensives, and 52 
patients with gestational hypertension. The mean maternal 
age, race, and parity of these three groups did not differ 
significantly.  
The preeclamptic patients had significant hypocalciuria  
compared to people who had normal blood pressure .The 
blood pressure and proteinuria were significantly increased in 
the preeclampsia group .using statistical analysis a urine 
calcium threshold of 12 mg/dL was chosen as cutoff for 
prediction  of preeclampsia, with a sensitivity, specificity, of  
85% and 91%, respectively.  
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The PPV -85 and NPV - 91%.They concluded that 
Urinary calcium levels below 12 mg/dL may help distinguish 
preeclampsia from other hypertensive disorders of 
pregnancy.(8) 
 
Efficacy of CCR in spot urine and proteinuria as a 
screening tool for preeclampsia. 
A study published by Rodriguez MH et al in American 
journal was conducted in Dept of OBG, Southern California 
School of Medicine, Los Angeles. 
88 normotensive gravid women between 24 and 34 
weeks of gestation underwent urine evaluation for the 
presence of microalbuminuria and urinary calcium excretion 
(calcium/creatinine ratio).  
Preeclampsia subsequently developed in 83% of 
patients with a high level of microalbuminuria (greater than 
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or equal to 11 micrograms/ml) and a low CCR .Conversely, 
94% of women who did not demonstrate high 
microalbuminuria and a low calcium/creatinine ratio 
remained normotensive at the time of delivery.  
These results suggest that changes in renal function are 
present in gravid women who are otherwise free of symptoms 
in which preeclampsia will eventually develop.  
They concluded the study saying that testing for 
microalbuminuria and a CCR can be used as assessment tool 
in  early prediction of preeclampsia.(9) 
 
Hypocalciuria as predictor of preeclampsia. Study done by 
Sanchez et al showed that,  
Hypocalciuria is associated with pre eclampsia, whether 
the symptoms occur before or after the pathogenesis set in, 
needs to be established .   
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In this study urinary calcium excretion was measured in 
103 primigravida at risk for developing preeclampsia less 
than 24 weeks of pregnancy. Multiple 24-hour urine samples 
were collected 24 weeks, 32 weeks, and 33 weeks to term. 
Post delivery, the values were evaluated for the development 
of hypertensive disorder. 
Patients who developed preeclampsia had hypocalciuria 
(169 +/- 30 mg/24 hours) when compared to normal 
population (298 +/- 15 mg/24 hours) with P value less than 
.05, this levels were observed during pregnancy. Statistical 
analysis was done and PPV and NPV were obtained for 
calcium excretion levels of 195 mg/24 hours.  
The difference in the incidence of preeclampsia 
between pregnant women with calcium excretion values at or 
below 195 mg/24 hours and those with values above that 
level was highly significant .with P value less than .0001. 
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These observations suggest that hypocalciuria may be related 
to the progression of hypertensive disorder during pregnancy.  
 
(11) The CCR and PROTEINURIA in Predictors of 
Preeclampsia published by Sheela CN et al. 
Study conducted in Dept of OBG St. John’s Medical 
College & Hospital, Bangalore  
Aim was to evaluate the urinary CCR and proteinuria as 
a marker for early prediction of preeclampsia. They Screened 
200 asymptomatic women attending their clinic for pre 
eclampsia by doing CCR in spot urine and also 
microalbuminuria at 20 to 24 weeks of pregnancy. 
They had taken the cutoff of 0.04 .The results were 
analysed and they concluded saying that there was significant 
association between low calcium excretion and development 
of pre eclampsia.   
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Statistical results of sensitivity, specificity, PPV and 
NPV of 69.2%, 98.2%, 85.7% and 95.8% respectively and p 
value was statistically very significant. It was found to be a 
good test for prediction of preeclampsia.  
The study determined that pre eclampsia is associated 
with low calcium excretion at threshold for CCR at 0.04, so 
CCR in spot urine can be used as screening method in early 
pregnancy as a primary prevention for development of pre 
eclampsia.  
 
Diagnostic efficacy of proteinuria and the CCR in the 
early prediction of hypertensive disorder in pregnancy, 
published in Spanish by, Martínez de Giordano D et al, study 
was conducted in Cátedra de Clínica Obstétrica  
Perinatología H.U.M.N., Córdoba. 
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They have evaluated the biochemical and clinical 
parameters for early detection of their alterations in pregnant 
women with late preeclampsia. Eighty nine patients between 
24 and 32 gestation weeks were studied. Fifteen of them 
(18%) developed arterial hypertension (mean 141.5 +/- 
3mmHg). 
The perinatal results, gestational age at delivery, birth 
weight and Apgar score of the newborns were not 
significantly different among the groups that were evaluated. 
The microalbuminuria was analyzed through 
radioimmunoanalysis and reactive strips for the 
immunochemical semi quantitative determination. 
They concluded the study with above results 
mentioning that no significant differences were found among 
the results of each evaluated method. The RIA showed 
greater sensibility, greater specificity and greater positive or 
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negative predictive value with respect to other methods, but 
the differences were not wide enough to consider it the 
method of choice. 
In the group of patients (n = 15) who developed arterial 
hypertension, all the biochemical methods showed a 
normality higher than 80%. They concluded that none of 
these methods used alone is useful for the early prediction of 
the appearance of preeclampsia 
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MATERIALS AND METHODS 
 
The study was conducted in the dept of OBG, PSG 
Hospitals, and Coimbatore from July 2012 to May 2013. 
STUDY DESIGN 
         Prospective study 
STUDY POPULATION 
         The study group consisted of 200 samples, randomly 
selected from the pateints attending the antenatal clinic from 
gestational age 24 weeks to 34 weeks.  
INCLUSION CRITERIA 
Singleton pregnancy 
Gestational age 24 to 34weeks 
Multipara with no history of hypertension 
  
34 
 
EXCLUSION CRITERIA  
Chronic hypertension 
Renal disease  
Multiple Pregnancy 
Autoimmune diseases  
Diabetes complicating pregnancy 
Previous abruption 
Previous IUGR 
Previous history of PIH  
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METHODOLOGY 
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200 antenatal women who attended the PSG hospitals 
obstetrics and gynecology department outpatient department, 
from july 2012 to may 2013 at 24 to 34 weeks of gestation 
were enrolled in the study. 
Informed consent was obtained from the patients for 
urinary CCR estimation.  
Antenatal women with history of hypertension, diabetes 
and renal disease and women with the disorders mentioned in 
exclusion criteria were removed from the trail. 
Women with a higher blood pressure of more than or 
equal to 140/90mm Hg were excluded   from the study. All 
women were examined in detail and obtained history in detail 
about past and present illness. Anyone with the history 
suggestive of  illness as mentioned in the exclusion criteria 
were not involved in the study. 
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Blood pressure (BP) was measured in the right arm 
sitting position. The urine sample was collected at the 
collection center and sent to bio chemistry laboratory for 
estimation of CCR. 
The doctors and patients were blinded from the CCR 
values; they were observed and followed up regularly up to 
delivery.  
Each and every patient involved in the trail was 
observed closely for signs and symptoms of pre eclampsia, 
like increased weight gain, reduced urine output, swelling of 
ankle, headache, epigastric pain, blurring of vision. 
At delivery the mode of delivery and birth weight of the 
new born was noted to determine the secondary outcomes. 
The data was collected at the end of the study and entered in 
the excel spread sheet and statistical analysis was done for 
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determing the sesnsitivity, specificity, PPV, NPV of CCR in 
determination of pre eclampsia. 
GESTATIONAL HYPERTENTION  
Defined as Blood pressure of more than or equal to 
149/90 without protienuria 
PREECLAMPSIA  
Defined as blood pressure of more than or equal to 
140/90 mmHg associated with protein excretion.   
The women in the study were categorized bases on 
above definition as normotensive or hypertensive. 
CCR values were determined and the levels less than or 
equal to <0.04+_0.04 were considered as low calcium 
excretion, I e positive,  
Those with a ratio of >0.08 were considered as normal 
calcium excretion I e negative. The PPV, NPV, sensitivity, 
specificity of calcium to creatinine ratio is determined by 
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statistical analysis. Pearson correlation was established 
between normal group and the group who developed pre 
eclampsia with age, birth weight, and gestational age of 
development od pre eclmapsia 
OUTCOME MEASURES 
Development of pre eclampsia  
Gestational age of development of pre eclampsia   
Mode of delivery  
Birth weight  
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PRO FORMA 
 
NAME  
AGE 
SERIL NO 
OP NUMBER  
 IP NUMBER 
ADDRESS  
UNIT 
SOCIO ECONOMIC STATUS 
MENSTRUAL HISTORY 
OBSTETRIC HISTORY 
GESTATIONAL AGE OFCOLLECTION  
ANTENATAL COMPLICATION 
PR 
BLOOD PRESSURE AT BOOKING 
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EDEMA 
ICTERUS 
CVS  
RS 
PA 
CALCIUM CREATININE RATIO 
GESTATIONAL AGE OF COLLECTION 
FOLLOW UP- 
GESTATIONAL AGE OF DEVELOPMENT OF PRE 
ECLAMPSIA 
COMPLICATION  
MODE OF DELIVERY 
BIRTH WEIGHT 
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PSG Institute of Medical Science and Research, Coimbatore 
Institutional Human Ethics Committee 
INFORMED CONSENT 
 
 
I, Dr. SINDHU.D, MD., (OG) postgraduate from the 
department of Obstetrics and Gynecology of PSG Institute of 
Medical Science & Research (PSGIMS&R), am carrying out 
a study on the topic: To Asses the predictive value of calcium 
creatinine ratio in spot urine sample for early prediction of 
pre eclampsia. 
Under the aegis of the Department of Obstetrics and 
Gynecology, PSGIMSR   
The objectives of this study are: 
To Asses the predictive value of calcium creatinine 
ratio in spot urine sample for early prediction of pre 
eclampsia. 
  
44 
 
Sample size: 200 
Respondents are patients at 24 to 34 weeks of gestation, 
who attended the outpatient department. PSG hospitals 
coimbatore 
Consent: The above information regarding the study, has 
been read by me/ read to me, and has been explained to me 
by the investigator/s. Having understood the same, I hereby 
give my consent to them to interview me. I am affixing my 
signature / left thumb impression to indicate my consent and 
willingness to participate in this study.  
Signature / Left thumb impression of the Study 
Volunteer / Legal Representative:  
 
 
Signature of the Interviewer with date:   Witness: 
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Results 
During the study period a total of 200 patients were 
included in the study. 
 
BOX 1 
No of postives and negatives 
 
Among 200 samples 18 patients had abnormal CCR and 
182 had normal values, i,e 18 were positives and 182 
negatives CCR- Calcium Creatinine Ratio 
 
Test parameter Test positive (n%) Test negative (n%) Total (n%) 
CCR 18 (9.0%) 182(91%) 200(100%) 
47 
 
 
BOX 2 
The correlation of CCR with pre eclampsia 
 
CCR Pre-Eclampsia Normotensive Total 
Test Positive 5 (2.5%) (True Positive) 
13 (6.5%) 
(False Positive) 18 (9.0%) 
Test Negative 2(1%) (False Negative) 
180(90%) 
(True Negative) 182(91%) 
Total 7(3.5%) 193(96.5%) 200(100%) 
  
 
Among the 18 positive values,5 were true positives that is 
they developed pre eclampsia and 13 were false positive that 
is they failed to 
results ,2 were false negative meaning they developed pre 
eclampsia with normal CCR values and rest 180 were true 
negatives with normal CCR and normal blood pressure
48 
Fig 1 
develop pre eclampsia, among 182 negative 
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BOX 3 
Results of statistical analysis 
 
The sensitivity of CCR in prediction of pre eclampsia is 
71% and specificity is 86%. 
With very low PPV and good NPV of 98.8% 
  
Test parameter Criteria Sensitivity Specificity PPV NPV 
CCR <0.04+_ 0.04 71.43 86.01 15.6 98.8 
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Area under curve of CCR 
Fig 2 
 
  
Predictive Value of CCR in PIH
AUC - Calcium Creatinine Ratio(CCR)
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Test parameter AUC SE 95% CI 
CCR 0.74 0.16 0.67-0.80 
 
The Area under the Curve of CCR in predicting  
Pre eclampsia  is 0.74 
Sensitivity is 71.43%  
Specificity is 86.01% 
The PPV is 15.6% 
The NPV is 98.8% 
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BOX 4 
Correlation of pre eclampsia and CCR with age, BW, GA at 
delivery 
Pearson Correlation CCR Pre-Eclampsia 
 
Correlation 
Coefficient P Value 
Correlation 
Coefficient P Value 
Age 0.100 0.160 0.075 0.293 
BW 0.148 0.036 -0.029 0.682 
GA at delivery 0.115 0.106 -0.065 0.362 
CCR 
  
-0.110 0.122 
Pre-Eclampsia -0.110 0.122 
  
 
CCR-Calcium Creatinine ratio  
BW-Birth Weight  
GA-Gestational Age 
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Normal CCR is found to have positive Pearson 
correlation with age, birth weight (BW) (statistically 
significant), implying that normal CCR samples had 
appropriate age, normal birth weight and   term gestational 
age (GA) at delivery. 
Whereas CCR has negative Pearson correlation with 
pre-eclampsia, suggesting that normal CCR had very low 
incidence of pre eclampsia. 
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BOX 5 
Correlation of pre eclampsia with age, BW, GA of 
delivery and CCR  
 
CCR-Calcium Creatinine ratio  
BW-Birth Weight  
GA-Gestational Age 
 
Parameters Normotensive PIH P Value 
Age 24.73 26.29 0.2926 
BW 2.92 2.86 0.6825 
GA at Delivery 38.75 38.29 0.3621 
Calcium Creatinine 
Ratio 0.25 0.15 0.1221 
  
Diagnosis of Pre
correlation with age, 
common in younger age group.
Whereas Negative correlation with birth weight, 
gestational age and C
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Fig 3 
-Eclampsia has positive Pearson 
incidence of pre eclampsia is seen more 
 
CR,with P Value not significant
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BOX 6 
Correlation of CCR with age, BW, GA of delivery and CCR 
 
 
CCR-Calcium Creatinine ratio  
BW-Birth Weight  
GA-Gestational Age 
 
Parameters Normal CCR 
Abnormal 
CCR P Value 
Age 24.73 25.28 0.566 
BW 2.93 2.81 0.2338 
GA at Delivery 38.74 38.67 0.8191 
Calcium Creatinine 
Ratio 0.27 0.04 <0.01 
 CCR is found to have positive Pearson correlation with 
age, birth weight (statistically significant) and gestational 
age, whereas CCR has negative Pearson correlation with pre
eclampsia.  
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Fig 4 
 
 
-
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BOX 7 
Correlation of mode of delivery with CCR 
 
 
 
Mode of Delivery Normal CCR % 
Abnormal 
CCR % 
NVD 122 67.03 15 83.33 
LSCS 59 32.42 3 16.67 
IUD Term 1 0.55 0 0.00 
Total 182 
 
18 
 
 Mode of delivery had negative correlation with CCR, 
83.3% of patients with abnormal CCR had normal delivery 
compared to normal CCR 
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Fig 5 
 
only 67% had normal delivery
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BOX 8 
Correlation of mode of delivery with pre eclampsia 
 
Mode of 
Delivery Normotensive % Pre eclampsia % 
NVD 132 68.39 5 71.43 
LSCS 60 31.09 2 28.57 
IUD Term 1 0.52 0 0.00 
Total 193 
 
7 
 
 
NVD - Normal Vaginal Delivery  
LSCS – Lower Segment Caesarean  
IUD –Intra Uterine Demise 
  
No significant correlation was established between 
mode of delivery and pre eclampsia
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Fig 6 
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62 
 
 
 
 
 
 
 
 
DISCUSSION 
  
63 
 
DISCUSSION 
 
In the above study comprising of 200 low risk anenatal 
mothers at 24-34 weeks of pregnancy were enrolled in the 
study. They all were assessed for development of pre 
eclampsia by determining the CCR in the urine sample.  
They were categorized into pre eclampsia and 
normotensive depending on the low CCR less than or equal 
to 0.04 +_0.04 .Out of 200 samples, 18 calcium creatinine 
ratio was found to be abnormal, of which 5 developed pre 
eclampsia and rest 13 remained normotensive throughout 
pregnancy, and 2 samples with normal value developed pre 
eclampsia showing,  
Sensitivity of 71%,  
Specificity of 86%  
NPV of 98.8%   
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PPV of 15.6% 
Low calcium creatinine ratio has positive pearson 
correlation with the age, birth weight and gestational age of 
delivery, where as it has negative correlation with pre 
eclampsia. 
 
Sheela et al , from St Jhons medical college conducted 
a study, Calcium creatinine and microalbuminuria in ratio in 
spot urine  sample for prediction of pre eclampsia at 20 to 24 
weeks of gestation  they reported that, the sensitivity of 
69.2%, specificity of 98.2%, PPV of 85.7% and NPV of 87% 
with statistically significant p value. 
They concluded saying that a determination of CCR at 
less than or equal to 0.04, in a urine sample, in low risk  
women  at 20-24 weeks of gestation is a better predictor 
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preeclampsia and  can  be recommended as a screening test 
for all pregnant women.  
Where as in our study, we estimated only calcium 
creatinine ratio, and found to have sensitivity of 71%, 
specificity of 86% with a good NPV of 98.8% and PPV of 
15.6%. 
Concluding that CCR has got good NPV and better 
specificity but cannot be used as a routine screening method 
for prediction of preeclampsia, may be it can be used as more 
randomized trials with more sample size are needed for 
determining the efficacy of CCR in predicting pre eclampsia. 
 
Ozcan conducted a trail where the efficacy of 
determining the hypocalciuria in urine sample for early 
prediction of pre eclampsia as early as in 1990 s and 
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concluded that low calcium excretion can be used as 
predictive marker of pre eclampsia. 
Preeclampsia whereas the above study shows it can be 
used as a screening tool, in low risk group, but can be used in 
the high risk group for its high negative predictive value. 
 
Saudan 6, had reported the sensitivity of Calcium 
creatinine ratio of only 68% and specificity of 70% with the 
threshold  cut off  value of 0.10,compared to the study stated 
above the threshold value is much lesser than the above 
value, which shows sensitivity of 71% and specificity of 
86%,NPV of 98.8% and PPV of 15%. 
 
Izumi  had reported  that the CCR  had reduced value as 
a screening method of pre eclampsia, but screening was done  
in initial  period of pregnancy, at less than or equal to 12 
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weeks, where as in the above study the gestational age is 
taken from 24 to 34 weeks, giving a wider range for 
prediction.  
 
Kazeroomi et al and Kar et al  established the efficacy 
of  low calcium excretion in  early prediction of pre 
eclampsia at less than or equal to 0.04 at 20-34weeks of 
pregnany and concluded saying  that CCR can be used as a  
early marker of  pre eclampsia. 
 
Saudan PJ et al conducted a study in Dept of Renal 
Medicine, Australia. 
They wanted to prove the fact that Hypocalciuria has 
been associated with hypertensive disorder in pregnancy with 
or without proteinuria, but not with normal pregnancy. They 
stressed up on the fact that low calcium excretion can be used 
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as a marker of imminent preeclampsia in women at high risk 
for developing preeclampsia. 81 women with established 
hypertension in second half of pregnancy were included in 
the study. The CCR was determined in a urine sample at first 
visit.  
The Patients were observed and subsequently classified 
according to development of preeclampsia post natally.on 
follow up, patients who developed pre eclampsia had low 
calcium excretion antenatally, compared to the population 
who remained normotensive. Results of statistical analyses 
revealed sensitivity 68% and a specificity of 70%. 
The pathogenesis of renal involvement in pre eclampsia 
has been proved to occur well before the establishment of 
symptoms .This test cannot be used  as a  sceerning test as 
the test lacks sensitivity for prediction of preeclampsia.(6) 
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Salako 10 has shown that urinary calcium excretion by 
determining CCR had a high sensitivity (88.9%) but a low 
PPV (22%), similar way as shown in the above study.  
 
Estimation of CCR in a spot urine sample is a feasible 
test, easy to perform and hence has high patient 
acquiescence. It has a good NPV and hence substantiates the 
cost and it may be suitable to be used as a screening tool for 
prediction of preeclampsia. 
It can therefore be suggested as a screening test for 
people who are high risk preeclampsia between 24-34 weeks 
of pregnancy. 
Preeclampsia is a chief cause for maternal mortality and 
morbidity worldwide, especially in developing countries and 
there has been a many research works going on for a better 
predictor and there but prevention of pre eclampsia. 
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 An accessibility of a good screening test would pledge 
and encourage more exploration work in the direction of 
primary prevention. 
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CONCLUSION 
 
A single estimation of CCR at less than or equal to 0.04 
+_0.04, in a spot urine sample, in asymptomatic pregnant 
women between 24-34 weeks of pregnancy, may be used as a 
early forecaster of pre eclampsia future development of 
preeclampsia in asymptomatic low risk women, but with high 
negative predictive value it can be used as screening tool for 
pre eclampsia in high risk group. 
More randomized trials with the bigger sample size is 
needed for confirmation. 
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STATISTICAL ANALYSIS 
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STATISTICAL ANALYSIS 
 
 
Data collected were entered in Excel Spread sheet and 
analyzed using STATA statistical software package release 
11. We used the two-sided independent-samples t test to 
compare means across dichotomous variables; the one-way 
ANOVA test for comparison of means across multilevel 
variables. Simple calculations like Percentages, Proportions 
and Mean values were derived. A type I error of 0.05 was 
considered in all analyses. Using ROC - AUC, the sensitivity, 
specificity, positive and negative predictive value of the test 
is calculated. 
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S.No. AGE CCR GA OF COLLECTION GA OF PIH
GA OF 
DELIVERY MODE WEIGHT
1 24 0.204 26 WK 37 WK LSCS 2
2 23 0.359 24 WK 39 WK + 6D NVD 2.86
3 28 0.23 26 WK + 5 D 40 WK NVD 2.92
4 24 0.204 25 W + 6 D 37 WK LSCS 3.12
5 23 0.18 25 W + 6 D 39 WK NVD 2.89
6 27 0.374 33 WK 38 WK LSCS 2.98
7 23 0.44 26 W + 2 D 39WK + 5 D NVD 3.02
8 18 0.242 25 WK + 3 D 39 W + 4 D NVD 2.8
9 25 0.124 25WK + 6 D 39 WK + 6 D LSCS 2.34
10 28 0.522 24WK + 3 D 39 WK + 2 D LSCS 3.7
11 24 0.12 31 WKS 39 W+ 6 D LSCS 3.96
12 36 0.11 24 WK +  6 D 38 WK + 4 D LSCS 2.53
13 26 0.107 33 WKS 38 WKS NVD 3.2
14 25 0.119 26 W + 2 D 37 WKS NVD 2.7
15 27 0.18 24 WKS + 1 D 38 WKS LSCS 2.23
16 23 0.15 24 WKS 40 WK LSCS 3.4
17 28 0.159 26WK + 3 D 38 WKS NVD 3.22
18 20 0.123 24 W + 1 D 39 WKS NVD 2.96
19 18 0.035 28 WKS 38 WKS 39 WKS NVD 2.94
20 22 0.166 33W + 1D 39 WK NVD 2.98
21 21 0.169 29 WKS 40 WKS LSCS 3.07
22 20 0.137 24WKS 35 WKS NVD 1.98
23 27 0.408 24 WKS 39 WKS NVD 2.73
24 20 0.12 25 W + 1 D 39 WKS NVD 3.38
25 24 0.42 24 W + 5 D 38 WKS LSCS 2.74
26 23 0.29 27 WKS 33 WKS + 5 D NVD 2.14
27 25 0.07 25 W+ 6 D 36 WKS LSCS 1.66
28 27 0.321 32 WKS 39 WKS LSCS 3.1
29 25 0.307 30 WK + 1 D 37 WKS NVD 2.35
30 24 0.15 25 WKS 37 WKS NVD 2.8
31 27 0.116 31 WKS + 2 D 39 W + 4 D NVD 2.87
32 26 0.3 29 WKS 40 WKS NVD 2.97
33 21 0.246 26 WKS 39 WK + 3 D LSCS 2.88
34 21 0.219 24WKS 39 W+ 6 D NVD 3.25
35 22 0.118 24 W+ 1D 39 WKS LSCS 2.49
36 23 0.394 24W + 5 D 38 WKS + 2 D NVD 2.9
37 24 0.282 24 W + 4 D 38 WKS LSCS 2.96
38 25 0.311 28W + 1 D 37 WKS NVD 2.61
39 36 0.39 31 WKS + 3 D 32 WKS 38 WKS LSCS 3.08
40 26 0.17 27 W+ 2 D 38 WKS NVD 2.77
41 27 0.249 24 WKS 37 WKS NVD 2.31
42 23 0.039 24 WKS 40 WK NVD 3.14
43 26 0.161 29 WKS 39 W + 4 D NVD 3
44 31 0.56 25 WK + 3 D 38 WK NVD 2.9
45 26 0.144 29 WKS 40 WKS NVD 3.12
46 28 0.22 28 WK + 4 D 40 W + 1D NVD 2.48
47 27 0.62 27 WKS 39 WK +6D LSCS 3.45
48 26 0.2 26 WKS 40 WK LSCS 2.97
49 24 0.151 25 WK + 5 D 39 W + 4 D LSCS 3.05
50 20 0.08 34 WKS 38 WKS +3 D NVD 2.35
51 25 0.0236 32 WKS 38 WKS + 3 D NVD 2.42
52 24 0.271 26 WKS + 3 D 40 WKS NVD 3.64
53 34 0.09 24 WKS 40 WKS NVD 3.57
54 30 0.205 28 WKS 39 W + 4 D NVD 3.2
55 20 0.04 24 WKS + 6 D 39 WKS NVD 2.96
56 24 0.11 24 WKS 38 WKS NVD 3.11
57 30 0.42 24 WKS 39 WKS + 5 D NVD 2.86
58 22 0.435 29 WKS 39 WKS + 3 D NVD 2.8
59 23 0.066 29 WKS 40 WKS NVD 2.56
60 20 0.259 26 WKS 37 WKS NVD 2.76
61 25 0.19 27 WKS 38 WKS LSCS 2.5
62 29 0.34 26 W + 2 D 38 WKS LSCS 3
63 33 0.17 25 W + 3 D 40 WKS + 2 D NVD 3.01
64 22 0.6 26 WKS + 2 D 39 WKS + 1 D NVD 2.82
65 25 0.21 29 WKS 39 WK + 4 D LSCS 3.13
66 23 0.25 28 WK + 6 D 37 WK + 6 D NVD 2.9
67 27 0.44 24 WKS + 6 D 40 WKS NVD 4.33
68 24 0.32 27 WKS + 4 D 36 WKS + 6 D NVD 3.42
69 20 0.083 27 WKS + 2 D 38 WKS + 5 D NVD 2.12
70 23 0.5 28 WKS + 4 D 40 WKS NVD 3.1
71 26 0.16 25 WKS 37 WKS NVD 2.45
72 21 0.3 28 WKS 38 WKS LSCS 2.14
73 23 0.247 27 WKS 37WKS + 5 D NVD 3.08
74 23 0.1 28 WKS 38 WKS + 3 D NVD 2.42
75 27 0.154 28 WKS 38 WK + 4 D NVD 2.9
76 21 0.095 28 WKS 39 WKS + 1 D NVD 3.12
77 21 0.07 28 WKS 40 WKS LSCS 2.9
78 26 0.17 28 WKS 40 WKS NVD 3.3
79 24 0.25 27 WKS + 2 D 40 WKS NVD 3.13
80 25 0.329 28 WKS 37 W + 2 D NVD 2.21
81 26 0.12 28 WKS 39 WKS NVD 3.33
82 23 0.192 25 WKS + 6 D 40 WKS NVD 4.05
83 29 0.122 25 WKS + 1 D 39 WKS LSCS 2.6
84 27 0.06 29 WKS 38 WKS NVD 2.63
85 33 0.047 29 WKS 38 WKS LSCS 3.3
86 34 0.011 27 WKS + 6 D 38 WKS LSCS 2.3
87 20 0.007 25 W+ 6 D 38 WKS 39 WKS + 5 D NVD 2.8
88 24 0.08 22 WKS 39 WKS + 5 D NVD 3.31
89 26 0.03 26 WKS + 1 D 35 WKS + 6 D 39 WKS LSCS 3.14
90 31 0.036 28 WKS + 3 D 30 WKS + 3 D 35WK + 1 D NVD 2.25
91 25 0.511 29 WKS 36 WKS 37 WKS NVD 2.9
92 21 0.09 28 WKS 38 WKS + 4 D NVD 2.8
93 28 0.49 27 WKS 39 WK + 3 D LSCS 3.8
94 27 0.161 24 WKS 39 W + 4 D NVD 3.2
95 21 0.19 24 WKS + 5 D 38 WKS +3 D NVD 3.1
96 22 0.176 26 WKS 40 WKS NVD 2.8
97 22 0.156 24 WK + 5 D 40 WKS + 2 D NVD 2.9
98 22 0.09 26 WKS 39 WKS + 6 D LSCS 3
99 22 0.167 26 WKS + 5 D 39 WKS + 6 D NVD 2.8
100 26 0.21 26 WKS 38 WK + 4 D NVD 2.67
101 23 0.317 24 WKS 40 WKS + 2 D LSCS 3.01
102 23 0.36 24 WKS + 4 D 40 WKS NVD 3.01
103 27 0.264 27 WKS 37 WKS + 2 D NVD 2.73
104 31 0.1 24 WKS + 5 D 40 WKS + 2 D NVD 3.03
105 27 0.8 27 WKS 40 WKS + 2 D NVD 3.1
106 27 0.109 26 W + 2 D 37 WKS + 5 D LSCS 2.42
107 28 0.18 25 WKS 37 WKS NVD 2.02
108 24 0.24 24 WKS 39 WKS + 6 D LSCS 2.19
109 26 0.3 24 WKS 39 WKS + 4 D LSCS 3.11
110 26 0.386 24 WKS 40 WKS LSCS 3.22
111 29 0.1 24 WKS 38 WKS + 4 D NVD 2.57
112 20 0.34 26 WKS + 1 D 39 WKS + 3 D NVD 2.9
113 21 0.28 29 WKS 32 WKS NVD 1.65
114 21 0.4 24 WKS 37 WKS + 3 D NVD 2.95
115 26 0.5 25 WKS 39 WKS + 6 D NVD 3.3
116 26 0.1 27 WKS 37 WKS + 3 D NVD 2.5
117 18 0.24 25 WKS 39 W+ 6 D NVD 2.9
118 22 0.33 24 WKS 40 WKS + 2 D LSCS 3.9
119 26 0.03 25 WKS 37 WKS + 2 D NVD 3.13
120 20 0.16 28 WKS 40 WKS LSCS 3.75
121 27 0.2 30 WKS 38 WKS + 4 D NVD 3.29
122 24 0.5 25 WKS 39 WKS + 4 D LSCS 2.8
123 33 0.7 28 WKS 38 WKS LSCS 3.15
124 26 0.36 24 WKS 38 WKS + 2 D LSCS 2.75
125 18 0.16 26 WKS 37 WKS + 6 D NVD 3.11
126 22 0.98 28 WKS 39 W + 4 D NVD 2.8
127 24 0.168 26 WKS + 5 D 40 WKS NVD 3.3
128 32 0.187 25 WKS 36 WKS + 4 D NVD 2.42
129 27 0.241 29 WKS 40 WKS LSCS 3.38
130 20 0.03 28 WKS 39 WKS + 3 D NVD 3
131 21 0.121 25WKS 39 WKS + 1D NVD 2.9
132 24 0.21 27 WKS 37 WKS + 6 D NVD 2.3
133 26 0.01 24 WKS + 6 D 40 WKS NVD 2.54
134 18 0.133 24 WKS 37 WKS + 6 D NVD 2.87
135 26 0.2 26 WKS 38 WKS + 5 D LSCS 2.8
136 24 0.33 24 WKS 39 WKS + 1 D NVD 3.01
137 27 0.48 25 WKS 38 WKS NVD 2.73
138 24 0.09 26 W + 2 D 39 WKS + 1 D NVD 2.8
139 23 0.3 26 WKS 39 WKS + 5 D LSCS 2.77
140 23 0.12 29 WKS 38 WKS + 4 D NVD 3.34
141 28 0.25 28 WKS 37 WKS + 6 D LSCS 2.73
142 26 0.29 30 WKS 38  WKS + 1 D IUD TERM 2.6
143 19 0.24 28 WKS 37 WKS + 5 D NVD 2.8
144 28 0.2 28 WKS 39 WKS + 5 D LSCS 3.47
145 20 0.1 28 WKS 34 WKS + 6 D NVD 1.98
146 23 0.08 24 WKS 39 WKS + 1D NVD 2.98
147 32 0.2 28 WKS 37 WKS + 3 D LSCS 3
148 23 0.9 24 WKS 39 WKS + 4 D NVD 3.12
149 18 0.37 26 WKS 39 WKS NVD 2.82
150 26 0.134 27 WKS 37 WKS + 3 D NVD 2.5
151 21 O.286 29 WKS 38 WK NVD 2.8
152 28 0.615 27 WKS 39 W+ 6 D NVD 2.92
153 26 O.386 26 WKS 39 W + 4 D LSCS 3.22
154 33 0.123 30 WKS 37 WKS + 4 D LSCS 3.12
155 21 0.246 27 WKS 39 WKS LSCS 2.88
156 31 0.67 26 WKS 40 WKS NVD 2.95
157 23 0.28 29 WKS 40 WKS NVD 3.25
158 19 0.197 29 WKS 40 WKS NVD 3.5
159 18 0.16 26 WKS 37 WKS NVD 3.11
160 20 0.489 26 WKS 40 WKS + 2 D NVD 2.85
161 26 0.554 25 WKS 39WKS + 6 D NVD 3.3
162 32 0.364 28 WKS 38 WKS + 2 D LSCS 3.27
163 24 0.4 25 WKS 38 WKS +3 D NVD 2.9
164 33 0.78 28 WKS + 2D 39 WKS LSCS 3.15
165 29 0.403 28 WKS 38 WKS LSCS 2.44
166 20 0.161 29 WKS 40 WKS LSCS 3.71
167 32 0.155 27  WKS 38 WKS LSCS 3.07
168 20 0.564 26 WKS 39 WKS + 3 D NVD 2.9
169 24 0.19 26 WKS 40 WKS NVD 3.4
170 23 0.8 29 WKS 38  WKS + 1 D NVD 3.1
171 28 0.42 27 WKS 37 WKS NVD 3.12
172 24 0.036 24 WKS 38 WKS + 4 D NVD 2.8
173 23 0.07 30 WKS 38 WKS + 3 D NVD 3
174 27 0.018 28 WKS 39 W+ 6 D NVD 2.9
175 23 0.09 28 WKS 39 W + 4 D LSCS 3.6
176 18 0.54 26 W + 2 D 40 W + 1D NVD 3.1
177 25 0.3 26 W + 2 D 39WKS + 6 D NVD 3.2
178 28 0.45 25 W+ 6 D 39 WKS + 6 D LSCS 2.9
179 24 0.76 25WKS 39 WKS + 3 D NVD 2.9
180 36 0.39 24 WK + 5 D 39 WKS + 3 D NVD 3
181 26 0.23 25 WKS 39 WKS + 1D NVD 3.11
182 25 0.33 26 WKS + 1 D 37 WKS + 6 D NVD 2.86
183 27 0.3 27 WKS + 2 D 40 WKS NVD 2.8
184 23 0.09 27 WKS 37 WKS + 6 D NVD 2.56
185 28 0.06 24 WKS + 4 D 38 WKS + 5 D NVD 2.76
186 20 0.2 25 W + 3 D 39 WKS + 1 D LSCS 2.5
187 18 0.113 24 WK + 5 D 38 WKS LSCS 3
188 22 0.14 26 W + 2 D 39 WKS + 1 D NVD 3.01
189 21 0.2 27  WKS 39 WKS + 5 D NVD 2.82
190 20 0.12 25 W + 3 D 38 WKS + 4 D LSCS 3.13
191 27 0.308 25 WKS 37 WKS + 6 D NVD 2.9
192 20 0.197 28 WKS 38  WKS + 1 D NVD 4.33
193 29 0.111 26 WKS + 1 D 38 WK LSCS 3.27
194 28 0.007 27  WKS 38+3D 39 W+ 6 D NVD 2.9
195 25 0.3 27  WKS 34 WKS + 6 D NVD 3.1
196 27 0.11 28 WKS 39 WKS + 1D NVD 2.45
197 25 0.112 27 WKS + 4 D 37 WKS + 3 D LSCS 2.14
198 24 0.282 26 WKS + 5 D 39 WKS + 4 D NVD 3.11
199 26 0.34 26 W + 2 D 39 WKS NVD 2.85
200 27 0.04 26 WKS 37 WKS + 3 D NVD 3.3
